What is Hoth Therapeutics Inc (HOTH) stock price today?

Hoth Therapeutics Inc (HOTH) currently trades at $0.71 per share. The stock has a market capitalization of $13.67M and a P/E ratio of —x.

Is HOTH stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Hoth Therapeutics Inc has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is —.

Is Hoth Therapeutics Inc financially healthy?

Hoth Therapeutics Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of — places it in the —.

HOTH

Hoth Therapeutics Inc

NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY

$0.71

-2.70% today

Updated 2026-04-29

Market cap

$13.67M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.90

Dividend yield

—

52W range

$0 – $2

Volume

3.1M

Market cap

$13.67M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.90

Dividend yield

—

52W range

$0 – $2

Volume

3.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.00

+599.79%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-2.15M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-11.37M	$-7.85M	$-8.19M	$-12.47M	$-2.69M
EPS	—	—	—	—	$-0.90
Free cash flow	$-9.37M	$-8.45M	$-6.98M	$-9.80M	$-2.15M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HOTH	$13.67M	21	4.3	3.0	5.0	6.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Hoth Therapeutics Inc trades at $0.71. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Hoth Therapeutics Inc's stock price?

Hoth Therapeutics Inc (HOTH) trades at $0.71.

Is Hoth Therapeutics Inc overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of Hoth Therapeutics Inc (HOTH)?

The analyst target price is $5.00, representing +599.8% upside from the current price of $0.71.

Piotroski F-Score?

1/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

hoththerapeutics.com

Quick metrics

P/S ratio—

ROE-191.40%

Beta0.60

50D MA$0.86

200D MA$1.17

Shares out0.02B

Float0.02B

Short ratio—

Avg volume3.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

HOTH vs LLY →HOTH vs JNJ →HOTH vs ABBV →Stock screener →